Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Takeda
Takeda
Takeda Seeks 10-Fold Jump in China Sales by 2015, Hasegawa Says
Bloomberg
Wed, 09/22/10 - 09:58 am
Takeda
China
FDA reviewing safety of Actos diabetes drug
MSNBC
Sat, 09/18/10 - 11:28 am
Actos
diabetes
Takeda
Speculative Bubble Growing Around Diet Drugs
BNET Pharma
Tue, 09/14/10 - 05:42 pm
Arena Pharmaceuticals
obesity
Takeda
Orexigen
Contrave
Abbott Laboratories
Meridia
Qnexa
Vivus
Alnylam Evenly Poised
Yahoo/Zacks.com
Fri, 09/10/10 - 08:15 am
Alnylam
Novartis
Biogen Idec
Roche
Isis Pharmaceuticals
Cubist Pharmaceuticals
Takeda
earnings
Volume Hunter: Diet Stocks Lift Biotech
Yahoo/IndieResearch
Thu, 09/2/10 - 04:01 pm
diet drugs
biotech
Arena Pharmaceuticals
Dendreon
Provenge
Exelixis
Vivus
Orexigen
Takeda
Contrave
Martek
Orexigen, Takeda Tie Knot on Obesity Drug
TheStreet.com
Thu, 09/2/10 - 08:18 am
Orexigen
Takeda
obesity
Contrave
partnerships
Takeda's Actos Has Same Heart Risks as Glaxo's Avandia, Researchers Find
Bloomberg
Wed, 08/25/10 - 07:53 am
diabetes
Takeda
Actos
GSK
Avandia
Takeda Says Lifestyle-Disease Drugs Will Drive Growth
Bloomberg
Thu, 08/19/10 - 10:33 am
Takeda
diabetes
Actos
generics
Affymax Lives to Fight Another Day
Motley Fool
Mon, 08/9/10 - 11:06 am
Affymax
anemia
Takeda
Amgen
A Faster Pathway to Drug Approvals
Motley Fool
Sun, 08/1/10 - 02:26 pm
Europe
FDA
drug approvals
AMA
Eli Lilly
Takeda
Pfizer
Eisai
Epix
It's All About the Future for Amylin
Motley Fool
Thu, 07/22/10 - 03:49 pm
Amylin
Bydureon
Byetta
diabetes
Novo Nordisk
Victoza
Merck
Januvia
Takeda
Actos
Onglyza
AstraZeneca
If Avandia falls, which diabetes meds fill the gap?
Fierce Pharma
Wed, 07/14/10 - 12:09 pm
diabetes
GSK
Avandia
Actos
Takeda
Merck
Januvia
Novo Nordisk
Victoza
Eli Lilly
Byetta
Amylin
Onglyza
AstraZeneca
Bristol-Myers Squibb
Affymax Sell-Off: Did Investors Overreact?
Seeking Alpha
Thu, 07/8/10 - 09:27 am
Affymax
Amgen
Takeda
EPO
Epogen
Micera
Roche
investors
Takeda Allocates $1.7 Billion for Product Purchases Over Next Three Years
Bloomberg
Thu, 07/8/10 - 08:57 am
Takeda
M&A
Avandia, Heart Attacks & An Upcoming FDA Meeting
Pharmalot
Mon, 06/28/10 - 01:43 pm
Avandia
heart attacks
GSK
diabetes
FDA
Actos
Takeda
In a New Study, Treatment With JANUMET® (sitagliptin/metformin), Merck's Diabetes Medicine, Resulted In Significantly Greater Blood Sugar Lowering Compared with Pioglitazone
Yahoo/BusinessWire
Sun, 06/27/10 - 11:07 am
Januvia
Merck
pioglitazone
diabetes
type 2 diabetes
Actos
Takeda
Amgen's EPO Drugs Dodge a Bullet as Hematide Stumbles, but the Big Biotech's Trials Aren't Over
BNET Pharma
Tue, 06/22/10 - 12:31 pm
Amgen
Hematide
anemia
Affymax
Takeda
Takeda, CanBas: Ended Joint Study On Cancer Drug
Nikkei,com, Japan
Thu, 06/17/10 - 10:12 am
Takeda
CanBas
lung cancer
Nexium, Protonix Linked to Bone Fractures, FDA Says
Bloomberg
Wed, 05/26/10 - 08:54 am
fractures
Nexium
Protonix
Prevacid
AstraZeneca
Takeda
Pfizer
proton pump inhibitors
Takeda, Astellas Trim Costs as Generics Hurt Profit
Bloomberg
Thu, 05/13/10 - 06:52 am
Takeda
Astellas
generics
layoffs
Pages
« first
‹ previous
…
34
35
36
37
38
39
40
41
42
next ›
last »